ARCHIVES

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

Tobacco Research Council Awards Six New Grants

July 4, 1975

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999

Cancer Centers Form Network To Compete For Managed Care, Develop Standards

January 27, 1995

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

August 8, 2008

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006